Palatin Technologies (PTN) will transfer its common stock listing to Nasdaq Capital Market from NYSE American later this month, the biopharmaceutical company said late Monday.
The company's common stock will continue trading on the NYSE American until May 28 and is expected to begin Nasdaq trading May 29 under the existing ticker, it said.
The Nasdaq listing should "improve the visibility" of the stock, improve trading liquidity and increase exposure to institutional investors, Chief Executive Carl Spana said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments